跳至主要内容
临床试验/NCT02982356
NCT02982356Unknown不适用

Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy

Shanghai First Maternity and Infant Hospital0 个研究点目标入组 1,300 人开始时间: 2017年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
1,300
主要终点
Success rate for the operation

研究概览

简要总结

The risk of abnormal chromosome and structure is much higher in twins than in singletons, and traditional early pregnancy screening strategy for single pregnancy is not suitable for twins. Based on our management experience of fetal medicine at twin pregnancy, and multi-center cooperation, the study will carry out the following clinical studies:

  1. to explore a suitable, early, noninvasive and accurate prenatal screening strategy for twin pregnancy.
  2. fetal chromosomal abnormalities

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ultrasound diagnosis as twin pregnancy
  • at 11-14 gestational weeks

排除标准

  • Multiple pregnancies (three or more)
  • Maternal history of chromosome aneuploidy abnormality or tumor

研究组 & 干预措施

Fetal Selective Reduction Technology

Other

Potassium chloride fetal heart injection in the dichorial twins with abnormal chromosome and structure

干预措施: Fetal Selective Reduction Technology (Procedure)

Fetal Selective Reduction Technology

Other

Potassium chloride fetal heart injection in the dichorial twins with abnormal chromosome and structure

干预措施: Potassium Chloride (Drug)

结局指标

主要结局

Success rate for the operation

时间窗: 1 week

次要结局

  • long-term complications after surgery(1 year)

研究者

申办方类型
Other
责任方
Sponsor

相似试验